Plethora Solutions


  • Effective from the first dose
  • Takes 5 minutes to work
  • Over 85% of men had delayed ejaculation time of greater than 1 min
  • Effectiveness was maintained with repeat use over time
  • Incidence of side-effects ( < 10%), no serious drug related adverse events
  • Ejaculation time continues to increase as drug treatment is continued for several months
  • Discreet and easy to use aerosol
  • Significantly increased ejaculatory control, sexual satisfaction and reduced stress
  • Subject of controlled clinical trials

The Premature Ejaculation Bothersome Evaluation Questionnaire (PEBEQâ„¢) is a proprietary tool which can be used by the physicians to address the multi-dimensional concept of bothersomeness experienced by men with premature ejaculation. If you wish to use this questionnaire to assess your patients then please contact Plethora:

1.Summary of Product Characteristics
2.Carson C, Wyllie M. J. Sex. Med. 2010;7(9):3179-89.

Last updated: 6th March 2018 - UK/Fortacin/002

This Product is a proprietary development stage pharmaceutical although the European MAA has been authorized by the European Commission. Information contained on this website is provided for business development and investor relations purposes only. Patients who suffer or believe they suffer from PE should contact their physician in the first instance.